Shouxiangu(SH:603896) Zheng Quan Zhi Xing·2025-05-23 09:21Core Viewpoint - The legal opinion letter confirms that the actual controller of Zhejiang Shouxiangu Pharmaceutical Co., Ltd., Mr. Li Zhenyu, has legally increased his shareholding in the company, complying with relevant laws and regulations [3][12]. Group 1: Shareholding Increase Details - Mr. Li Zhenyu directly held 5,114,161 shares before the increase, accounting for 2.58% of the total share capital [8]. - After the increase, Mr. Li Zhenyu holds 9,078,961 shares, representing 4.58% of the total share capital [10]. - The total shareholding controlled by Mr. Li Zhenyu and his concerted actors reached 40.77% after the increase [10]. Group 2: Compliance and Legal Qualification - Mr. Li Zhenyu is confirmed to have full civil capacity and meets the qualifications to be a shareholder of a listed company, with no prohibitive conditions as per the regulations [8][12]. - The increase in shareholding was executed through the Shanghai Stock Exchange, totaling 3,964,800 shares, which is 2% of the total share capital, and the total amount spent was approximately RMB 82.0992 million [9][10]. - The increase complies with the provisions of the Securities Law and the M&A Regulations, and it qualifies for exemption from making a tender offer [12]. Group 3: Information Disclosure - The company has fulfilled its information disclosure obligations regarding the shareholding increase, as evidenced by announcements made on May 6 and May 13, 2025 [11]. - The legal opinion letter states that the company must continue to fulfill its disclosure obligations regarding the implementation of the shareholding increase plan [11].